Cargando…
Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
The mutants resulted from the ongoing SARS-CoV-2 epidemic have showed resistance to antibody neutralization and vaccine-induced immune response. The present study isolated and identified two novel SARS-CoV-2 neutralizing antibodies (nAbs) from convalescent COVID-19 patients. These two nAbs (XG81 and...
Autores principales: | Xie, Jiajia, Ding, Chengchao, He, Jun, Zhang, Yuqing, Ni, Shuangshuang, Zhang, Xiangyu, Chen, Qingqing, Wang, Jing, Huang, Lina, He, Hongliang, Li, Wenting, Ma, Huan, Jin, Tengchuan, Zhang, Siping, Gao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442604/ https://www.ncbi.nlm.nih.gov/pubmed/34539645 http://dx.doi.org/10.3389/fimmu.2021.715464 |
Ejemplares similares
-
Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021) -
Advances in the Isolation of Specific Monoclonal Rabbit Antibodies
por: Zhang, Zaibao, et al.
Publicado: (2017) -
Expression of Recombinant Antibodies
por: Frenzel, André, et al.
Publicado: (2013) -
HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes
por: Bezstarosti, Suzanne, et al.
Publicado: (2022) -
PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy
por: Lu, Dan, et al.
Publicado: (2022)